1 – 10 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Drug Resistance in HIV-Positive Adults During the Initial Year of Antiretroviral Treatment at Ethiopian Health Centers
(
- Contribution to journal › Article
-
Mark
Interferon-g-Inducible Protein 10 (IP-10) Kinetics after Antiretroviral Treatment Initiation in Ethiopian Adults with HIV
(
- Contribution to journal › Article
- 2020
-
Mark
Brief Report : Interferon-γ-Inducible Protein 10-A Potential Marker for Targeted Viral Load Monitoring of Antiretroviral Treatment?
(
- Contribution to journal › Article
-
Mark
Low-Level Viremia during ART and the Risk of Death, AIDS, and Serious Non-AIDS-events
(
- Contribution to conference › Abstract
-
Mark
Socio-economic condition and lack of virological suppression among adults and adolescents receiving antiretroviral therapy in Ethiopia
(
- Contribution to journal › Article
-
Mark
All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Virus Viremia During Combination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study
2020) In Clinical Infectious Diseases(
- Contribution to journal › Article
- 2019
-
Mark
Is low-level HIV-1 viraemia associated with elevated levels of markers of immune activation, coagulation and cardiovascular disease?
(
- Contribution to journal › Article
- 2018
-
Mark
HIV-genetic diversity and drug resistance transmission clusters in Gondar, Northern Ethiopia, 2003-2013
(
- Contribution to journal › Article
- 2017
-
Mark
Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment
(
- Contribution to journal › Article
-
Mark
Development of an algorithm for determination of the likelihood of virological failure in HIV-positive adults receiving antiretroviral therapy in decentralized care
(
- Contribution to journal › Article